Wu, W.-S.; Chen, R.-F.; Cheng, C.-C.; Wei, J.-L.; Lin, C.-F.; You, R.-I.; Chen, Y.-C.; Lee, M.-C.; Chen, Y.-C.
Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma. Pharmaceutics 2022, 14, 2698.
https://doi.org/10.3390/pharmaceutics14122698
AMA Style
Wu W-S, Chen R-F, Cheng C-C, Wei J-L, Lin C-F, You R-I, Chen Y-C, Lee M-C, Chen Y-C.
Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma. Pharmaceutics. 2022; 14(12):2698.
https://doi.org/10.3390/pharmaceutics14122698
Chicago/Turabian Style
Wu, Wen-Sheng, Rui-Fang Chen, Chuan-Chu Cheng, Jia-Ling Wei, Chen-Fang Lin, Ren-In You, Yen-Chang Chen, Ming-Che Lee, and Yen-Cheng Chen.
2022. "Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma" Pharmaceutics 14, no. 12: 2698.
https://doi.org/10.3390/pharmaceutics14122698
APA Style
Wu, W.-S., Chen, R.-F., Cheng, C.-C., Wei, J.-L., Lin, C.-F., You, R.-I., Chen, Y.-C., Lee, M.-C., & Chen, Y.-C.
(2022). Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma. Pharmaceutics, 14(12), 2698.
https://doi.org/10.3390/pharmaceutics14122698
